Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study

Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study

Abstract Background Mother-to-child transmission (MTCT) is one of the main routes of transmission of HBV, and previous studies focused on the efficacy and safety of nucleoside analogues (NAs) in preventing MTCT. There are limited data on virologic changes of chronic hepatitis B (CHB) patients after...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Qiao Tang, Chunrui Wang, Hu Li, Zhiwei Chen, Li Zhang, Jing Zhang, Xiaoqing Liu, Yunling Xue, Yue Qiu, Mingli Peng, Yi Zeng, Peng Hu
Формат:	Өгүүллэг
Хэл сонгох:	English
Хэвлэсэн:	BMC 2025-02-01
Цуврал:	Virology Journal
Нөхцлүүд:	Mother-to-child transmission ALT abnormal Liver fibrosis Virologic response Treatment discontinuation
Онлайн хандалт:	https://doi.org/10.1186/s12985-025-02632-x

Ижил төстэй зүйлс

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
-н: Luisa Roade, зэрэг
Хэвлэсэн: (2023-10-01)

Circulating immune complexes and mutations of HBsAg are associated with the undetectable HBsAg in anti-HBs and HBeAg positive occult hepatitis B virus infection
-н: Ying Yan, зэрэг
Хэвлэсэн: (2022-11-01)

Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients
-н: Jing Zhao, зэрэг
Хэвлэсэн: (2023-03-01)

Deteksi HBsAg dan HBeAg dalam Saliva Pengidap Virus Hepatitis B
-н: Riemawati A. Lesmana
Хэвлэсэн: (2015-10-01)

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.
-н: Tung-Hung Su, зэрэг
Хэвлэсэн: (2013-01-01)

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL
-н: Chih-Chien Yao, зэрэг
Хэвлэсэн: (2017-05-01)

Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia
-н: Crozier Sarah, зэрэг
Хэвлэсэн: (2008-04-01)

Quantitative HBsAg: Not helpful to evaluate fibrosis in HBeAg-negative chronic hepatitis B patients
-н: Dimitri Loureiro, зэрэг
Хэвлэсэн: (2019-01-01)

Correlation between HBsAg quantitation and HBV DNA in HBeAg-Negative HBV/D patients
-н: Anouar Teriaky, зэрэг
Хэвлэсэн: (2013-01-01)

Triple motif proteins 19 and 38 correlated with treatment responses and HBsAg clearance in HBeAg-negative chronic hepatitis B patients during peg-IFN-α therapy
-н: Haiying Luo, зэрэг
Хэвлэсэн: (2023-07-01)

Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area
-н: Chen-Hsuan Wu, зэрэг
Хэвлэсэн: (2017-04-01)

Coexistence of HBsAg/Anti-HBs and HBeAg/Anti-HBe in Sudanese Patients with Chronic Hepatitis B Virus Infection: A Cross-Sectional Study
-н: Taqwa Hashim, зэрэг
Хэвлэсэн: (2023-12-01)

End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation
-н: Yifei Guo, зэрэг
Хэвлэсэн: (2023-02-01)

Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues.
-н: Teresa Broquetas, зэрэг
Хэвлэсэн: (2017-01-01)

Quantitative HBsAg levels do not identify hepatic fibrosis in HBeAg-negative chronic hepatitis B patients
-н: Fatima A Ahmed, зэрэг
Хэвлэсэн: (2019-01-01)

Quantitative HBsAg and Qualitative HBeAg Predicts Intrauterine Placental Infection and Umbilical Blood Cord in Pregnant Women
-н: Erry Gumilar Dachlan, зэрэг
Хэвлэсэн: (2020-10-01)

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
-н: Cheng-Yuan Peng, зэрэг
Хэвлэсэн: (2015-04-01)

CTLA-4 haplotype predicts HBsAg and HBcrAg levels and HBeAg seroconversion age in children with chronic HBV infection
-н: Jia-Feng Wu, зэрэг
Хэвлэсэн: (2024-05-01)

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
-н: Shengxia Yin, зэрэг
Хэвлэсэн: (2023-12-01)

HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
-н: Michel Bazinet, зэрэг
Хэвлэсэн: (2022-08-01)

Caucasian Ethnicity, but Not Treatment Cessation Is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion
-н: Stijn Van Hees, зэрэг
Хэвлэсэн: (2019-07-01)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
-н: Romina Salpini, зэрэг
Хэвлэсэн: (2020-01-01)

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative
-н: Zhan Zeng, зэрэг
Хэвлэсэн: (2023-01-01)

Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients treated with nucleotide analogs plus polyethylene glycol interferon
-н: Yan Peng, зэрэг
Хэвлэсэн: (2025-01-01)

Mitogen-activated protein kinase eight polymorphisms are associated with immune responsiveness to HBV vaccinations in infants of HBsAg(+)/HBeAg(−) mothers
-н: Meng Zhuo Cao, зэрэг
Хэвлэсэн: (2018-06-01)

Alteration of the Immune Microenvironment in HBsAg and HBeAg Dual-Positive Pregnant Women Presenting a High HBV Viral Load
-н: Gao F, зэрэг
Хэвлэсэн: (2021-10-01)

Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels.
-н: Elisabetta Loggi, зэрэг
Хэвлэсэн: (2013-01-01)

Increased Coffee Intake Reduces Circulating HBV DNA and HBsAg Levels in HBeAg-Negative Infection: A Cohort Study
-н: Jack Bee Chook, зэрэг
Хэвлэсэн: (2019-09-01)

Possible immunochemical pattern of anti-HCV, HBeAg, HBsAg HBeAb, and HIV-1 p24 in newly infected Mycobacterium pulmonary tuberculosis patients
-н: Mathew Folaranmi Olaniyan, зэрэг
Хэвлэсэн: (2019-01-01)

Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
-н: Won-Mook Choi, зэрэг
Хэвлэсэн: (2022-05-01)

Correlation of fulminant hepatitis B, HBeAg start-codon depletions and escape mutations in the 2nd loop of the HBsAg a-determinant
-н: T. Michler, зэрэг
Хэвлэсэн: (2014-04-01)

Prevalence of HBe Ag and LFT Survey in HBsAg Positive Blood Donors in Kerman
-н: M.J Zahedi, зэрэг
Хэвлэсэн: (2003-07-01)

HBsAg clearance and seroconversion case in a patient with HBeAg-negative chronic hepatitis B on pegylated interferon α-2a therapy
-н: K. V. Zhdanov, зэрэг
Хэвлэсэн: (2014-09-01)

Study of hepatic histomorphology in HBeAg+ and HBeAg− patients with CHB: Experience from Bangladesh
-н: Ayub Al Mamun, зэрэг
Хэвлэсэн: (2013-01-01)

Significant liver histological change is common in HBeAg-positive chronic hepatitis B with normal ALT
-н: Menghui Duan, зэрэг
Хэвлэсэн: (2024-07-01)

Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers
-н: Yong Poovorawan, зэрэг
Хэвлэсэн: (2012-07-01)

Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA
-н: Jian Wang, зэрэг
Хэвлэсэн: (2024-12-01)

Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function.
-н: Tai-Long Chien, зэрэг
Хэвлэсэн: (2016-01-01)

Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/ anti-HBe Status in HBV Carriers
Хэвлэсэн: (2006-01-01)

PgRNA closely correlates to cytokine profile in HBeAg-positive pregnant women undergoing prophylactic antiviral intervention
-н: Qiao Tang, зэрэг
Хэвлэсэн: (2024-12-01)